290.56
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$289.70
Aprire:
$290.68
Volume 24 ore:
824.75K
Relative Volume:
0.64
Capitalizzazione di mercato:
$56.33B
Reddito:
$316.65B
Utile/perdita netta:
$1.91B
Rapporto P/E:
29.89
EPS:
9.72
Flusso di cassa netto:
$1.14B
1 W Prestazione:
-4.32%
1M Prestazione:
+0.07%
6M Prestazione:
+16.69%
1 anno Prestazione:
+24.44%
Cencora Inc Stock (COR) Company Profile
Nome
Cencora Inc
Settore
Industria
Telefono
610-727-7000
Indirizzo
1 WEST FIRST AVENUE, CONSHOHOCKEN
Confronta COR con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
COR
Cencora Inc
|
290.56 | 55.89B | 316.65B | 1.91B | 1.14B | 9.72 |
![]()
MCK
Mckesson Corporation
|
683.51 | 84.45B | 377.60B | 3.35B | 5.67B | 25.08 |
![]()
CAH
Cardinal Health Inc
|
149.24 | 34.87B | 222.58B | 1.57B | 1.85B | 6.45 |
![]()
HSIC
Henry Schein Inc
|
68.98 | 8.30B | 12.50B | 314.00M | 421.00M | 2.44 |
![]()
AHG
Akso Health Group Adr
|
1.74 | 972.09M | 2.22M | -5.63M | -1.68M | -0.24 |
Cencora Inc Stock (COR) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-06-03 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
2024-12-04 | Ripresa | Mizuho | Outperform |
2024-09-18 | Downgrade | BofA Securities | Buy → Neutral |
2024-02-26 | Iniziato | Leerink Partners | Outperform |
2024-01-03 | Iniziato | Barclays | Overweight |
2023-12-14 | Iniziato | Wells Fargo | Equal Weight |
2023-03-31 | Iniziato | Citigroup | Buy |
2023-01-31 | Ripresa | Evercore ISI | Outperform |
2022-10-11 | Aggiornamento | BofA Securities | Neutral → Buy |
2022-08-22 | Ripresa | Morgan Stanley | Equal-Weight |
2022-07-11 | Downgrade | Evercore ISI | Outperform → In-line |
2022-06-07 | Aggiornamento | Deutsche Bank | Hold → Buy |
2022-05-26 | Aggiornamento | Barclays | Equal Weight → Overweight |
2022-04-12 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2022-04-01 | Ripresa | Credit Suisse | Outperform |
2021-03-12 | Ripresa | Evercore ISI | In-line |
2021-02-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
2021-02-02 | Aggiornamento | Cowen | Market Perform → Outperform |
2021-01-06 | Aggiornamento | BofA Securities | Underperform → Neutral |
2021-01-06 | Aggiornamento | Credit Suisse | Neutral → Outperform |
2020-12-10 | Downgrade | Wells Fargo | Equal Weight → Underweight |
2020-12-03 | Iniziato | Mizuho | Neutral |
2020-08-06 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2020-07-15 | Iniziato | Barclays | Underweight |
2020-06-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2020-04-23 | Ripresa | Credit Suisse | Outperform |
2020-04-16 | Downgrade | Raymond James | Outperform → Mkt Perform |
2020-04-13 | Downgrade | Robert W. Baird | Outperform → Neutral |
2020-04-01 | Aggiornamento | JP Morgan | Neutral → Overweight |
2020-03-17 | Aggiornamento | Citigroup | Neutral → Buy |
2020-02-11 | Downgrade | BofA/Merrill | Buy → Underperform |
2020-02-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
2019-09-12 | Iniziato | Deutsche Bank | Hold |
2019-07-10 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
2019-04-11 | Iniziato | Guggenheim | Buy |
2019-04-10 | Downgrade | BofA/Merrill | Buy → Underperform |
2019-04-10 | Downgrade | Evercore ISI | Outperform → In-line |
2019-02-11 | Downgrade | JP Morgan | Neutral → Underweight |
2019-01-17 | Iniziato | UBS | Buy |
2018-12-10 | Downgrade | Jefferies | Buy → Hold |
2018-10-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
2018-09-20 | Iniziato | Berenberg | Buy |
2018-07-17 | Ripresa | Stifel | Hold |
2018-04-09 | Iniziato | MoffettNathanson | Buy |
2018-03-12 | Aggiornamento | KeyBanc Capital Mkts | Sector Weight → Overweight |
2018-03-12 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2017-09-25 | Iniziato | JP Morgan | Neutral |
2017-09-22 | Iniziato | William Blair | Outperform |
Mostra tutto
Cencora Inc Borsa (COR) Ultime notizie
Lead Independent Director Mark Durcan to Become Cencora Chairman, Bringing Tech Innovation Experience - Stock Titan
Risk vs reward if holding onto Cencora Inc.Trade Exit Report & Community Consensus Picks - Newser
Cencora (COR) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance
Reversal indicators forming on Cencora Inc. stockJuly 2025 Trade Ideas & Long-Term Growth Portfolio Plans - Newser
Real time social sentiment graph for Cencora IncEarnings Beat & Technical Buy Zone Confirmation - Newser
Real time social sentiment graph for Cencora Inc.Earnings Recap Summary & Daily Profit Maximizing Trade Tips - Newser
News impact scoring models applied to Cencora Inc.Trade Entry Summary & Low Risk Entry Point Tips - Newser
Should you wait for a breakout in Cencora Inc.Weekly Trade Review & AI Driven Price Predictions - Newser
Cencora Inc. stock volume spike explainedTrade Signal Summary & Growth Oriented Trading Recommendations - Newser
Has Cencora Inc. found a price floorMarket Volume Summary & AI Enhanced Trading Signals - Newser
Is Cencora Inc. meeting your algorithmic filter criteria2025 Trade Ideas & Stock Portfolio Risk Management - Newser
Will Cencora Inc. see short term momentumPortfolio Gains Report & Consistent Income Trade Ideas - Newser
Has Cencora Inc. formed a bullish divergencePortfolio Gains Report & Weekly Stock Performance Updates - Newser
Real time alert setup for Cencora Inc. performanceWeekly Trade Analysis & Consistent Income Trade Recommendations - Newser
Historical volatility pattern of Cencora Inc. visualizedMarket Performance Report & Free Long-Term Investment Growth Plans - Newser
Using data tools to time your Cencora Inc. exitJuly 2025 Trade Ideas & Real-Time Market Sentiment Alerts - Newser
What does recent volatility data suggest for Cencora Inc.Treasury Yields & Proven Capital Preservation Tips - Newser
Will earnings trigger a reversal in Cencora Inc.July 2025 Catalysts & Consistent Income Trade Recommendations - Newser
Is Cencora Inc. stock ready for a breakoutMarket Trend Summary & Reliable Volume Spike Trade Alerts - Newser
Risk adjusted return profile for Cencora Inc. analyzedJuly 2025 Fed Impact & Precise Buy Zone Tips - Newser
Visual analytics tools that track Cencora Inc. performanceJuly 2025 Gainers & Precise Buy Zone Identification - Newser
How to manage a losing position in Cencora Inc.July 2025 Outlook & Fast Exit/Entry Strategy Plans - Newser
Predicting Cencora Inc. trend using moving averagesEarnings Recap Report & AI Based Buy and Sell Signals - Newser
Can Specialty and GLP-1 Momentum Support Cencora's Q3 Results? - MSN
Custom watchlist performance reports with Cencora Inc.Quarterly Trade Report & Trade Opportunity Analysis Reports - Newser
Why Cencora Inc. stock is on top investor watchlists2025 Fundamental Recap & Fast Gaining Stock Strategy Reports - beatles.ru
Cencora Inc. Uptrend in Early Stages Indicators Say YesJuly 2025 Earnings & Intraday High Probability Alerts - beatles.ru
Will Cencora Inc. Bounce From 52 Week LowJuly 2025 Weekly Recap & Free Long-Term Investment Growth Plans - beatles.ru
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Cencora Director and CEO Buy and Sell Shares in August 2025 - AInvest
Published on: 2025-08-21 02:56:19 - classian.co.kr
Cencora directors ink $111M deal related to opioid claims - MSN
Cencora Inc. Rebound Backed by Sentiment ShiftWeekly Market Report & Safe Investment Capital Preservation Plans - kangso.co.kr
Cencora Posts Modest 1.5 Gain as Volume Plunge Sends Stock to 405th Trading Rank Amid Sector Restructuring Focus - AInvest
How Cencora Inc. stock performs during market volatilityQuarterly Performance Summary & Fast Entry and Exit Trade Plans - Newser
Visualizing Cencora Inc. stock with heatmaps2025 Earnings Surprises & Capital Efficiency Focused Strategies - Newser
What makes Cencora Inc. stock price move sharplyJuly 2025 Reactions & Verified Entry Point Signals - newsyoung.net
Cencora directors settle opioid claims for $111M - AInvest
Has Cencora Inc. Stock Ever Crashed Historical Volatility ReviewTrade Exit Summary & Reliable Price Breakout Alerts - Newser
Cencora directors ink $111M opioid deal (COR:NYSE) - Seeking Alpha
Cencora Shares Dip 0.70% as $320M Volume Ranks 332nd Amid Strategic Shifts and Sector Volatility - AInvest
Cencora Inc Azioni (COR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):